Drug Target Ontology

Other names: DTO

Drug Target Ontology (DTO) is developed as a reference for drug targets with the longer-term goal to create a community standard that will facilitate the integration of diverse drug discovery information from numerous heterogeneous resources. The first version of the DTO consists of asserted class hierarchies of the four IDG protein families, GPCRs, kinases, ion channels, and nuclear hormone receptors. Protein classes are linked to tissue and disease via different levels of confidence. DTO also contains drug target development classifications, a large collection of cell lines from the LINCS project and relevant cell-disease and cell-tissue relations. DTO is modeled in OWL2-DL to enable further classification by inference reasoning and SPARQL queries. DTO is implemented following a modularization approach. DTO will serve as the organizational framework for drug targets in the IDG PHAROS User Interface Portal (https://pharos.nih.gov).

Webpage:
http://drugtargetontology.org/

Licence:
Name: Creative Commons Attribution 3.0 Unported (CC BY 3.0)
URL: https://creativecommons.org/licenses/by/3.0/

Publications:

Tags:

disease protein

More to explore:

1/20



Need help integrating and/or managing biomedical data?